TELO
Telomir Pharmaceuticals, Inc.
1.20$
-2.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 0.0% | 2.9% | 9.1% | 100.0% | 100.0% | |
| 0.0% | 2.9% | 0.0% | 95.6% | 99.3% | |
| – | 2.9% | 0.0% | 95.6% | 99.3% | |
| – | – | 2.7% | – | – | |
| – | – | 6.4% | – | – | |
| 251.1% | 2,023.4% | 28.0% | 51.4% | 19.5% | |
| 251.1% | 2,023.4% | 28.0% | 51.4% | 19.5% | |
| 217.1% | 1,193.9% | 2.1% | 7.1% | 6.5% | |
| 34.1% | 829.5% | 14.8% | 44.4% | 7.3% | |
| -151.1% | -1,923.4% | 72.0% | 48.6% | 80.5% | |
| -251.1% | -2,036.3% | -294.6% | -2,310.9% | -558.6% | |
| 53,836.0% | 60,763.0% | 620.3% | 2,231.1% | 431.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.